Table 1: All patients' characteristics.
All patients (n = 469) |
|
|
|
Age (years) |
86.90 (5.97) |
Female |
358 (76.33) |
Body mass index, kg/m² |
22.15 (3.99) |
FRACTURE |
Cervical: 240 (51.17) Pertrochanteric: 229 (48.83) |
Walking immediately allowed |
389 (83.3) |
MEDICAL BACKGROUND |
|
Congestive heart failure |
43 (9.19) |
High blood pressure |
278 (59.4) |
Diabetes |
44 (9.4) |
Stroke |
58 (12.39) |
Stroke with sequela hemiplegia |
8 (1.71) |
Myocardial infarct |
61 (13.03) |
Obliterating arterial disease of the lower limbs |
29 (6.2) |
Chronic liver disease |
3 (0.64) |
Peptic ulcer |
19 (4.06) |
Tumor |
128 (27.35) |
Tumor with metastasis |
12 (2.58) |
Repeated falls |
105 (24.36) |
Cognitive impairments |
247 (59.38) |
Dementia |
171 (41.3) |
Folstein’s MMSE score, /30 |
19.54 (7.37) |
Chronic alcohol use |
23 (4.91) |
Chronic lung disease |
33 (7.05) |
Charlson index |
7.19 (2.35) |
EVENTS DURING HOSPITALIZATION |
|
Blood transfusion |
121 (27.82) |
Infection |
64 (14.35) |
BIOLOGICAL CHARACTERISTICS |
|
Creatinine, µmol/L |
82.88 (43.38) |
Creatinine clearance, ml/min (CG) |
45.99 (18.78) |
Hemoglobin on admission, g/dL |
12.21 (1.73) |
Platelets on admission, /mm3 |
237,000 (9,533) |
Serum or plasma albumin, g/L |
31.09 (3.84) |
Vitamin D, nmol/L |
56.15 (32.04) |
TREATMENTS |
|
Number of treatments on admission |
4.80 (3.23) |
Antihypertensive |
280 (60.22) |
Anti diabetic |
35 (7.53) |
Benzodiazepine |
136 (29.31) |
Antidepressant |
131 (28.17) |
Neuroleptic |
20 (4.31) |
Morphine |
267 (57.05) |
Anti platelet agent |
159 (34.19) |
Anticoagulant |
75 (16.13) |
FUNCTIONAL INDEPENDENCE |
|
ADL on admission, /6 |
4.58 (1.76) |
ADL 6/6 on admission |
208 (49.06) |
Parker on admission, /9 |
6.32 (2.76) |
Parker 9/9 on admission |
180 (43.37) |
DISCHARGE FROM HOSPITAL |
Rehabilitation: 321 (68.44) Home: 81 (17.27) Institution: 49 (10.45) |
AVERAGE LENGTH OF STAY |
|
Total, days |
9.72 (4.92) |
After surgery, days |
8.07 (4.33) |
Data are mean +/- SD, median [25-75] interquartile, or number (percentage)